Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: bendamustine|DRUG: erlotinib|DRUG: Maintenance erlotinib
Sponsor: Ohio State University Comprehensive Cancer Center
Collaborators: National Comprehensive Cancer Network|Genentech, Inc.